Bausch Health Companies (BHC) Current Assets (2009 - 2026)
Bausch Health Companies (BHC) reported Current Assets of $6.0 billion for Q1 2026, up 4.29% on a YoY basis from $5.7 billion in Q1 2025, and down 2.91% sequentially from $6.2 billion in Q4 2025.
Bausch Health Companies (BHC) Current Assets (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Current Assets data on file, last reported at $6.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 4.29% year-over-year to $6.0 billion; the trailing twelve-month figure through Mar 2026 stood at $6.0 billion (up 4.29% YoY), and the FY2025 full-year result was $6.2 billion, up 6.63% from the prior year.
- Current Assets retreated to $6.0 billion in Q1 2026, from $6.2 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $6.5 billion in Q2 2025 to a low of $4.0 billion in Q3 2022.
- A 5-year average of $5.4 billion and a median of $5.4 billion in 2022 frame the typical range for Current Assets.
- Peak annual rise in Current Assets reached 31.76% in 2023, while the deepest fall reached 27.4% in 2023.
- Tracing BHC's Current Assets over 5 years: stood at $4.2 billion in 2022, then soared by 31.76% to $5.6 billion in 2023, then advanced by 3.18% to $5.8 billion in 2024, then increased by 6.63% to $6.2 billion in 2025, then retreated by 2.91% to $6.0 billion in 2026.
- Business Quant data shows BHC's Current Assets at $6.0 billion in Q1 2026, $6.2 billion in Q4 2025, and $6.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 5.98 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.98 Bn |
| Dec 31, 2025 | 6.16 Bn |
| Sep 30, 2025 | 6.25 Bn |
| Jun 30, 2025 | 6.51 Bn |
| Mar 31, 2025 | 5.73 Bn |
| Dec 31, 2024 | 5.77 Bn |
| Sep 30, 2024 | 5.35 Bn |
| Jun 30, 2024 | 5.21 Bn |
| Mar 31, 2024 | 5.40 Bn |
| Dec 31, 2023 | 5.60 Bn |
| Sep 30, 2023 | 5.05 Bn |
| Jun 30, 2023 | 4.46 Bn |
| Mar 31, 2023 | 4.24 Bn |
| Dec 31, 2022 | 4.25 Bn |
| Sep 30, 2022 | 4.01 Bn |
| Jun 30, 2022 | 5.42 Bn |
| Mar 31, 2022 | 5.84 Bn |
| Dec 31, 2021 | 5.61 Bn |
| Sep 30, 2021 | 5.32 Bn |
| Jun 30, 2021 | 5.45 Bn |